137 related articles for article (PubMed ID: 9153192)
1. Inhibition of protein geranylgeranylation causes a superinduction of nitric-oxide synthase-2 by interleukin-1beta in vascular smooth muscle cells.
Finder JD; Litz JL; Blaskovich MA; McGuire TF; Qian Y; Hamilton AD; Davies P; Sebti SM
J Biol Chem; 1997 May; 272(21):13484-8. PubMed ID: 9153192
[TBL] [Abstract][Full Text] [Related]
2. Inhibiting geranylgeranylation blocks growth and promotes apoptosis in pulmonary vascular smooth muscle cells.
Stark WW; Blaskovich MA; Johnson BA; Qian Y; Vasudevan A; Pitt B; Hamilton AD; Sebti SM; Davies P
Am J Physiol; 1998 Jul; 275(1):L55-63. PubMed ID: 9688935
[TBL] [Abstract][Full Text] [Related]
3. Protein geranylgeranylation, not farnesylation, is required for the G1 to S phase transition in mouse fibroblasts.
Vogt A; Qian Y; McGuire TF; Hamilton AD; Sebti SM
Oncogene; 1996 Nov; 13(9):1991-9. PubMed ID: 8934546
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of the prenylation of K-Ras, but not H- or N-Ras, is highly resistant to CAAX peptidomimetics and requires both a farnesyltransferase and a geranylgeranyltransferase I inhibitor in human tumor cell lines.
Lerner EC; Zhang TT; Knowles DB; Qian Y; Hamilton AD; Sebti SM
Oncogene; 1997 Sep; 15(11):1283-8. PubMed ID: 9315095
[TBL] [Abstract][Full Text] [Related]
5. Regulation of interleukin-1-beta-stimulated inducible nitric oxide synthase expression in cultured vascular smooth muscle cells by hemostatic proteins.
Durante W; Kroll MH; Orloff GJ; Cunningham JM; Scott-Burden T; Vanhoutte PM; Schafer AI
Biochem Pharmacol; 1996 Mar; 51(6):847-53. PubMed ID: 8602881
[TBL] [Abstract][Full Text] [Related]
6. Platelet-derived growth factor receptor tyrosine phosphorylation requires protein geranylgeranylation but not farnesylation.
McGuire TF; Qian Y; Vogt A; Hamilton AD; Sebti SM
J Biol Chem; 1996 Nov; 271(44):27402-7. PubMed ID: 8910319
[TBL] [Abstract][Full Text] [Related]
7. Both farnesyltransferase and geranylgeranyltransferase I inhibitors are required for inhibition of oncogenic K-Ras prenylation but each alone is sufficient to suppress human tumor growth in nude mouse xenografts.
Sun J; Qian Y; Hamilton AD; Sebti SM
Oncogene; 1998 Mar; 16(11):1467-73. PubMed ID: 9525745
[TBL] [Abstract][Full Text] [Related]
8. Calcium and protein kinase C mediate high-glucose-induced inhibition of inducible nitric oxide synthase in vascular smooth muscle cells.
Muniyappa R; Srinivas PR; Ram JL; Walsh MF; Sowers JR
Hypertension; 1998 Jan; 31(1 Pt 2):289-95. PubMed ID: 9453318
[TBL] [Abstract][Full Text] [Related]
9. Prenyltransferase inhibitors block superoxide production by pulmonary vascular smooth muscle.
Boota A; Johnson B; Lee KL; Blaskovich MA; Liu SX; Kagan VE; Hamilton A; Pitt B; Sebti SM; Davies P
Am J Physiol Lung Cell Mol Physiol; 2000 Feb; 278(2):L329-34. PubMed ID: 10666117
[TBL] [Abstract][Full Text] [Related]
10. Disruption of oncogenic K-Ras4B processing and signaling by a potent geranylgeranyltransferase I inhibitor.
Lerner EC; Qian Y; Hamilton AD; Sebti SM
J Biol Chem; 1995 Nov; 270(45):26770-3. PubMed ID: 7592913
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of geranylgeranyltransferase I decreases generation of vascular reactive oxygen species and increases vascular nitric oxide production.
Zuckerbraun BS; Barbato JE; Hamilton A; Sebti S; Tzeng E
J Surg Res; 2005 Apr; 124(2):256-63. PubMed ID: 15820256
[TBL] [Abstract][Full Text] [Related]
12. Signal transduction pathways of IL-1beta-mediated iNOS in pulmonary vascular smooth muscle cells.
Finder JD; Petrus JL; Hamilton A; Villavicencio RT; Pitt BR; Sebti SM
Am J Physiol Lung Cell Mol Physiol; 2001 Oct; 281(4):L816-23. PubMed ID: 11557585
[TBL] [Abstract][Full Text] [Related]
13. beta-very low density lipoprotein enhances inducible nitric oxide synthase expression in cytokine-stimulated vascular smooth muscle cells.
Takahashi M; Takahashi S; Shimpo M; Naito A; Ogata Y; Kobayashi E; Ikeda U; Shimada K
Atherosclerosis; 2002 Jun; 162(2):307-13. PubMed ID: 11996950
[TBL] [Abstract][Full Text] [Related]
14. Protein isoprenylation regulates secretion of matrix metalloproteinase 1 from rheumatoid synovial fibroblasts: effects of statins and farnesyl and geranylgeranyl transferase inhibitors.
Abeles AM; Marjanovic N; Park J; Attur M; Chan ES; Al-Mussawir HE; Dave M; Fisher MC; Stuchin SA; Abramson SB; Pillinger MH
Arthritis Rheum; 2007 Sep; 56(9):2840-53. PubMed ID: 17763406
[TBL] [Abstract][Full Text] [Related]
15. Inducible nitric oxide synthase in vascular smooth muscle cells from prehypertensive spontaneously hypertensive rats.
Singh A; Sventek P; Larivière R; Thibault G; Schiffrin EL
Am J Hypertens; 1996 Sep; 9(9):867-77. PubMed ID: 8879343
[TBL] [Abstract][Full Text] [Related]
16. Ras CAAX peptidomimetic FTI-277 selectively blocks oncogenic Ras signaling by inducing cytoplasmic accumulation of inactive Ras-Raf complexes.
Lerner EC; Qian Y; Blaskovich MA; Fossum RD; Vogt A; Sun J; Cox AD; Der CJ; Hamilton AD; Sebti SM
J Biol Chem; 1995 Nov; 270(45):26802-6. PubMed ID: 7592920
[TBL] [Abstract][Full Text] [Related]
17. The geranylgeranyltransferase-I inhibitor GGTI-298 arrests human tumor cells in G0/G1 and induces p21(WAF1/CIP1/SDI1) in a p53-independent manner.
Vogt A; Sun J; Qian Y; Hamilton AD; Sebti SM
J Biol Chem; 1997 Oct; 272(43):27224-9. PubMed ID: 9341167
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of farnesyl:protein transferase and geranylgeranyl:protein transferase inhibitor combinations in preclinical models.
Lobell RB; Omer CA; Abrams MT; Bhimnathwala HG; Brucker MJ; Buser CA; Davide JP; deSolms SJ; Dinsmore CJ; Ellis-Hutchings MS; Kral AM; Liu D; Lumma WC; Machotka SV; Rands E; Williams TM; Graham SL; Hartman GD; Oliff AI; Heimbrook DC; Kohl NE
Cancer Res; 2001 Dec; 61(24):8758-68. PubMed ID: 11751396
[TBL] [Abstract][Full Text] [Related]
19. High affinity for farnesyltransferase and alternative prenylation contribute individually to K-Ras4B resistance to farnesyltransferase inhibitors.
Fiordalisi JJ; Johnson RL; Weinbaum CA; Sakabe K; Chen Z; Casey PJ; Cox AD
J Biol Chem; 2003 Oct; 278(43):41718-27. PubMed ID: 12882980
[TBL] [Abstract][Full Text] [Related]
20. Halothane but not isoflurane attenuates interleukin 1beta-induced nitric oxide synthase in vascular smooth muscle.
Maeda H; Iranami H; Yamamoto M; Ogawa K; Morikawa Y; Senba E; Hatano Y
Anesthesiology; 2001 Aug; 95(2):492-9. PubMed ID: 11506125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
